WASHINGTON, D.C. - The Biden administration has scrapped its controversial plan to prohibit the sale of menthol-flavored throat lozenges, according to an announcement made by the Food and Drug Administration on Thursday.
The proposed ban, which was first unveiled last year, aimed to reduce youth access and appeal to menthol-flavored tobacco products. However, it drew intense pushback from public health experts, advocacy groups, and manufacturers of over-the-counter menthol cough drops and lozenges.